Email bulletin archive Archive December 2020 2.5 million people in Africa need urgent hepatitis B treatment High hepatitis C cure rate achieved in New York prisons London comes together to treat hepatitis C during lockdown Experimental treatments for NASH at the Liver Meeting Is this your copy of the infohep news bulletin? November 2020 News from the 2020 AASLD Liver Meeting Which people with chronic liver disease have higher COVID-19 risks? Fatty liver greatly increases vulnerability to COVID-19 in obese people Minimal monitoring of hepatitis C treatment is safe and effective Few countries will meet 2020 target for reducing viral hepatitis deaths Can investment in hepatitis C treatment be cost saving? Tenofovir alafenamide prevents mother-to-child hepatitis B virus transmission Some hepatitis B patients can safely stop antivirals NASVAC therapeutic vaccine may lead to functional cure of hepatitis B Is this your copy of the infohep news bulletin? October 2020 Fatty liver disease affects one in four in Europe Experimental treatments for NASH and NAFLD at the Digital International Liver Congress Diabetes raises the risk of liver damage in people with HIV Fatty liver disease common in people living with HIV and hepatitis B Test and treat reduces hepatitis C by 83% in Melbourne gay men with HIV Nobel Prize for hepatitis C discovery Is this your copy of the infohep news bulletin? September 2020 News from the 2020 Digital International Liver Congress Predicting liver cancer after hepatitis C is cured Immunotherapy for advanced liver cancer Liver disease risk in people with HIV COVID-19 and liver disease Experimental treatments for hepatitis B Hepatitis D treatment Hepatitis C elimination Is this your copy of the infohep news bulletin? August 2020 Coming soon: news from the Digital International Liver Congress EASL updates guidance on COVID-19 in liver disease patients Is hepatitis elimination feasible by 2030? COVID-19 slows hepatitis elimination Condomless sex sufficient to pass on hepatitis C between men Liver cancer risk after hepatitis C cure may be lower in people with HIV South Africa: delays in registering direct-acting antivirals for hepatitis C Hepatitis testing and treatment in homeless people International Liver Congress 2021 Is this your copy of the infohep news bulletin? July 2020 New WHO guidance on preventing mother-to-child transmission of hepatitis B Cirrhosis raises the risk of liver injury in COVID-19 patients How often does COVID-19 cause liver disorders? Hepatitis C drugs may offer a treatment option for COVID-19 COVID-19 toolkit for patient associations World Hepatitis Alliance webinar, 31 July 2020 – Ten years to go: prospects of reaching the 2030 elimination targets in the context of COVID-19 Hepatitis C doubles the risk of head and neck cancers Hepatitis C cure means many liver failure patients have a better chance at transplantation and recovery Women suffer less NAFLD but more advanced fibrosis Diabetes doubles the risk of advanced liver disease in NAFLD Is this your copy of the infohep news bulletin? June 2020 International NASH Day NASH is fastest-growing reason for a liver transplant in United States Bacterial infection of the heart on the rise among people with hepatitis C in United States Cameroon study shows hepatitis C treatment is feasible, highly effective in sub-Saharan Africa Hepatitis C in England: deaths decline but new infections steady since 2011 World Hepatitis Day website and campaign materials launched Is this your copy of the infohep news bulletin? May 2020 COVID-19 in chronic liver disease: advanced cirrhosis greatly raises risk of death Controversy: Does non-alcoholic fatty liver disease raise the risk of COVID-19? Weight gain after hepatitis C cure is common Short-course treatment for recent hepatitis C: some courses may be too short Non-alcoholic fatty liver disease affects a quarter of lean people living with HIV New estimates highlight need to step up the response to hepatitis D International Liver Congress 2020 to take place online Is this your copy of the infohep news bulletin? April 2020 Liver transplants and COVID-19 Fatty liver disease may increase risk of severe COVID-19 disease New resources on liver disease and COVID-19 Directly observed treatment for hepatitis C highly effective in people who inject drugs Hepatitis C transmission in men who have sex with men Is this your copy of the infohep news bulletin? March 2020 Liver specialists offer guidance on COVID-19 risks in liver patients Are people with chronic liver disease at higher risk of severe COVID-19 symptoms? Advice on coronavirus (SARS-CoV-2 / COVID-19) for people with viral hepatitis or liver disease All adults ages 18 to 79 should be screened for hepatitis C London sets out route map for hepatitis C elimination HIV-positive people with fatty liver disease are at high risk for fibrosis EASL postpones International Liver Congress 2020 until August Epclusa approved for children aged six and over in United States Is this your copy of the infohep news bulletin? February 2020 Hepatitis C treatment and prevention failing to reach people most affected Increase in clean needle and syringe provision essential for hepatitis C elimination Half of people who inject drugs in Middle East have hepatitis C 90% of injection drug users miss opportunities for HIV or HCV testing Hepatitis B treatment suboptimal in people with HIV in Africa Medicines Patent Pool and Mylan sign agreement to scale up access to first generic version of hepatitis C treatment glecaprevir/pibrentasvir Is this your copy of the infohep news bulletin? January 2020 London: hepatitis C elimination depends on testing scale-up HepCheck screening programme links 80% to hepatitis C care in 4 European countries Peer-led outreach improves uptake of hepatitis C care among homeless and people who use drugs Hepatitis C screening among PrEP users could eliminate hepatitis C infections in gay men in UK How to check drug interactions with hepatitis C drugs Programme provides medical lockers for homeless people to store prescriptions Hepatitis C-positive donors a viable option to expand heart donor pool Egypt screens 1.6 million school students for hepatitis C Is this your copy of the infohep news bulletin? 2022202120202019201820172016201520142013 Other pages in this section Latest news All the news Conference news Email bulletin archive